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1 BIT and SzB contributed equally to this work.The goal of the current study was to investigate the expression of transient receptor potential vanil-
loid-1 (TRPV1) on human in vitro differentiated monocyte-derived dendritic cells (DCs) and to dis-
sect the corresponding role of TRPV1-signaling in DC-speciﬁc functions. TRPV1 expression was
identiﬁed both at the protein and gene levels in human DCs. Moreover, the prototypic TRPV1 agonist
capsaicin speciﬁcally (i.e. via TRPV1) and dose-dependently inhibited cytokine-induced DC differen-
tiation, phagocytosis of bacteria, activation of DCs, and pro-inﬂammatory cytokine secretion. These
data introduce TRPV1-coupled signaling as a novel player in human monocyte-derived DC biology
with anti-inﬂammatory actions.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Capsaicin, the pungent ingredient of the hot chili peppers,
induces a ‘‘multiple response” of pain, desensitization, neurotox-
icity, and neurogenic inﬂammation [1]. These effects were exclu-
sively attributed to the action of capsaicin on nociceptive sensory
neurons expressing transient receptor potential vanilloid-1
(TRPV1, the ‘‘capsaicin receptor”), a non-selective, calcium-perme-
able ion channel [2]. Via activation of TRPV1, capsaicin was shown
to induce neuropeptide release from the sensory afferents, which
in turn, initiates vasodilation, ﬂare, and edema [1].
However, several workgroups have also shown that TRPV1-
coupled cellular mechanisms not only initiate neurogenic re-
sponses but the receptor may also mediate protective anti-
inﬂammatory processes in certain inﬂammatory/allergic animal
models [3,4]. Moreover, emerging recent evidence also suggest
that TRPV1 is expressed in various non-neuronal cell types as
well, including those involved in inﬂammation. Indeed, TRPV1
and capsaicin-induced signaling mechanisms were described on
polymorphonuclear leukocytes, mast cells, and macrophages [5–chemical Societies. Published by E7], and were shown to be involved both in pro-inﬂammatory
(e.g. stimulation of the synthesis and release of a wide array of
cytokines and growth factors) [5,8] as well as anti-inﬂammatory
(e.g. inhibition of NO synthase, inactivation of NF-jB) [6,9,10] cel-
lular responses.
Dendritic cells (DCs) represent a subset of professional antigen-
presenting cells which are able to capture and process antigens,
secrete cytokines and, following activation, migrate to lymph
nodes and activate various lymphocyte subsets. Hence, DCs act
as central players in the orchestration of tolerogenic and inﬂam-
matory immune responses [11,12].
Intriguingly, we possess limited and rather controversial data
on the expression and function of TRPV1 on DCs. Using mouse
bone-marrow derived DCs, Basu and Srivastava [13] have shown
that the activation of TRPV1 induces maturation and activation of
DCs, which results in the engagement of various immune func-
tions. Conversely, others [14] were unable to detect the molecular
or functional expression of TRPV1 on these cell types.
With respect to human DCs, we have identiﬁed TRPV1 on Lan-
gerhans cells of the human skin in situ [15]. However, we lack
data on the functional existence of TRPV1 on human DCs. There-
fore, in the current study, we have investigated the effects of cap-
saicin on human in vitro cultured monocyte-derived DCs, and
have dissected the corresponding role of TRPV1-signaling in DC
functions.lsevier B.V. All rights reserved.
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2.1. DC cultures
Monocytes were isolated from buffy coats by immunomagnetic
cell separation using anti-CD14-conjugated microbeads (Miltenyi
Biotech, Bergisch Gladbach, Germany) [16]. To induce the differen-
tiation of immature DCs (iDCs), monocytes were cultured in AIMV
medium (Invitrogen, Paisley, UK) supplemented with 80 ng/ml
GM-CSF and 100 ng/ml IL-4 (both from Peprotech, London, UK).
At day 2, the same amount of GM-CSF and IL-4 was added and
the cells were cultured for another 3 days. To generate matured
DCs (mDCs), iDCs were activated for 24 h with a ‘‘pro-inﬂammatory
cytokine cocktail” containing 80 ng/ml GM-CSF, 10 ng/ml TNF-a,
5 ng/ml IL-1b, 20 ng/ml IL-6 (all from Peprotech), and 1 lg/ml
PGE2 (Sigma–Aldrich, St. Louis, MO).
2.2. Flow cytometry
Phenotypic characterization of DCs was performed by ﬂow
cytometry using different ﬂuorochrome-conjugated antibodies:
CD83-FITC and CD14-PE (Beckman Coulter, Hialeah, FL); CD209/
DC-SIGN-FITC (BD Pharmingen, San Diego, CA); CCR7-PE (R&D Sys-
tems, Minneapolis, MN) as described before [16] by a FACSCalibur
ﬂow cytometer (BD Biosciences Immunocytometry Systems,
Franklin Lakes, NJ).
2.3. Immunocytochemistry
Acetone-ﬁxed DCs were immunolabeled using a rabbit anti-
TRPV1 primary antibody (1:200, Sigma–Aldrich) and a FITC-conju-Fig. 1. TRPV1 is expressed on human monocyte-derived DCs. (A) Western blot analys
determining expression of cytochrome C (Cyt-C). In each sample, the amount of TRPV1 wa
density values, OD). (B) TRPV1-immunoreactivity on iDCs as determined by immunoﬂ
absorption negative control (NC). Bar, 20 lm. (C) Q-PCR analysis of TRPV1 expression. Da
and are expressed as mean ± S.E.M. (n = 3–7). (D) Ca2+-imaging on fura 2-loaded iDCs
wavelengths were recorded. The ﬁgure is a representative of multiple determinations angated secondary antibody (1:200, Vector Laboratories, Burlingame,
CA) as described before [17].
2.4. Western blotting
To determine the expression of TRPV1 in DCs at various stages
of differentiation, the Western blot technique was applied as we
have described before [5,15,17,18].
2.5. Ca2+-imaging
The functionality of TRPV1 as a Ca2+-permeable channel was
assessed by fura-2-based Ca2+-imaging as described in our earlier
reports [19] using a dual wavelength monochromator system (Del-
tascan, Photon Technology International, New Brunswick, NJ).
2.6. Determination of viable cell numbers
The number of viable cells was determined by using the MTT
based colorimetric EZ4U proliferation assay (Biomedica, Vienna,
Austria) as described before [17–19].
2.7. Determination of apoptosis
A decrease in the mitochondrial membrane potential is one of
the earliest signs of apoptosis. To assess the process mitochondrial
membrane potential of DCs was determined by a Fluorescence Im-
age Plate Reader (FLIPR, FlexStation384 II, Molecular Devices, San
Francisco, CA) platform using a MitoProbe DiIC1(5) Assay Kit (Invit-
rogen) as described before [17,18].is of TRPV1 on monocytes (MC), iDCs, and mDCs. Equal loading was assessed by
s quantitated by densitometry and normalized to those of Cyt-C (normalized optical
uorescence (FITC, green). Nuclei were counterstained by DAPI (blue). Inset, pre-
ta of TRPV1 expression were normalized to the level of GAPDH of the same sample
and mDCs. Fluorescence ratio (F340/F380) values of excitations at 340 and 380 nm
d shows the effect of 1 lM capsaicin and 180 lM ATP (used as a positive control).
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As described before [17,18], necrotic cell death was determined
by assessing Sytox Green staining (Invitrogen) which dye is able to
penetrate (and then bind to the nucleic acids) only the necrotic
cells with ruptured plasma membranes.
2.9. Determination of phagocytotic activity
Phagocytosis was measured by the uptake of FITC-labeled Esch-
erichia coli bioparticles by the DCs using a VybrantTM Phagocytosis
Assay Kit (Invitrogen) following the manufacturer’s protocol. The
ﬂuorescence intensity values were measured by FLIPR.
2.10. Quantitative real-time PCR (Q-PCR)
RNAwas isolated from cells using TRIzol (Invitrogen) and Q-PCR
was performed on an ABI Prism 7000 sequence detection system
(Applied Biosystems, Foster City, CA) using TaqMan primers and
probes as described before [17–19].
2.11. ELISA
The production of various cytokines was assessed by speciﬁc
ELISA kits (BD Pharmingen) as described before [16,17].
2.12. Statistical analysis
Whenapplicable,datawereanalyzedusingatwo-tailedun-paired
t-test and P < 0.05 valueswere regarded as signiﬁcant differences.Fig. 2. Capsaicin inhibits differentiation of iDCs. (A) Flow cytometry analysis of DC-SIGN e
Median ﬂuorescence of the maximal intensity was deﬁned as 100%. Panel shows th
representative donor. Three-ﬁve additional experiments yielded similar results. (B) Flow
representative of multiple determinations on independent donors. (C) FLIPR assays as
necrosis (Sytox green accumulation) at day 5 of differentiation. Data represent mean ± S.
deﬁned as 100%. (D) Flow cytometry analysis of DC-SIGN expression on iDCs differentia
capsazepine (CPZ). Data represent mean ± S.E.M. of three independent experiments and3. Results and discussion
3.1. TRPV1-signaling inhibits DC differentiation
First, we measured the existence of TRPV1 on monocyte-
derived DCs. Using complementary techniques, here we provide
the ﬁrst evidence that both human peripheral blood monocytes
as well iDCs (and mDCs, see further details below) express
TRPV1 at the gene and protein levels (Fig. 1A–C). The existence
of TRPV1 was further veriﬁed by Ca2+-imaging revealing that this
Ca2+-permeable channel is indeed functional on iDCs and mDCs
(Fig. 1D). Of further importance, we also found that TRPV1
expression dramatically increased during the cytokine-induced
in vitro differentiation of monocytes to iDCs (Fig. 1A and C). It
appears, therefore, that human monocyte-derived DCs now
‘‘join” the emerging group of various non-neuronal human cell
populations (including inﬂammatory and immune cells) on
which the expression of functional TRPV1 was unambiguously
identiﬁed [5,13,15,17,19].
We then investigated the effect of the functional TRPV1 agonist
capsaicin. Long-term application (for 5 days from day 0) of capsa-
icin (even up to extremely high 50 lM concentration, data not
shown) did not induce the in vitro differentiation of human periph-
eral monocytes to iDCs as monitored by DC-SIGN expression
(Fig. 2A and B). Likewise, capsaicin did not signiﬁcantly alter the
viable cell number nor did it induce cell death of any form
(Fig. 2C). These data were in a marked contrast to those seen on
sensory neurons and on most of the TRPV1-expressing non-neuro-
nal cells where capsaicin induced a massive, mostly Ca2+-depen-
dent cytotoxicity [1–3,17,19]. Apparently, the Ca2+-handlingxpression on monocytes and differentiating iDCs tested daily during differentiation.
e effect of 10 lM capsaicin (CAPS) and 80 ng/ml GM-CSF + 100 ng/ml IL-4 on a
cytometry analysis of DC-SIGN expression at day 5 of differentiation. The ﬁgure is a
sessing viability (MTT), apoptosis (mitochondrial membrane potential, MMP) and
E.M. of four independent determinations and values of iDCs without capsaicin were
ted by cytokines in the presence of capsaicin (CAPS) from day 0 or 3, and of 5 lM
values of iDCs without capsaicin were deﬁned as 100%. *P < 0.05.
Fig. 3. Capsaicin inhibits phagocytosis of iDCs. (A) Phagocytotic activity of iDCs differentiated for 5 days by cytokines in the presence of capsaicin (CAPS) and 5 lM
capsazepine (CPZ) applied daily. (B) Phagocytotic activity of iDCs treated with CAPS and CPZ for 2 h at day 5. (C) Effect of CAPS on phagocytotic activity of iDCs in normal
(1.2 mM Ca2+) and Ca2+ free Hank’s Balanced Salt Solution (HBSS). In each panel, data represent mean ± S.E.M. of four independent determinations and mean values of the
untreated groups were deﬁned as 100%. *P < 0.05.
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cellular effects of the TRPV1-mediated Ca2+-inﬂux.
However, of great importance, capsaicin markedly inhibited the
cytokine-induced (IL-4 and GM-CSF) differentiation of iDCs
(expressions of DC-SIGN, CD11c, HLA-DR) (Fig. 2B and D, Supple-Fig. 4. Capsaicin inhibits maturation, activation, and migration of mDCs iDCs were tre
capsaicin (CAPS), 5 lM capsazepine (CPZ), or combination. (A) Flow cytometry analysis o
CCR7 (B) and selected cytokines (C). Data were normalized to the level of GAPDH of the sa
Expressions on mDCs were deﬁned as 100%. ND, not detectable. (D) Secretion of selecte
determinations. *P < 0.05.mentary Fig. S1). This effect was most probably mediated by TRPV1
since the antagonist capsazepine (5 lM) [20] effectively prevented
the action of capsaicin to suppress DC-SIGN expression (Fig. 2D). Of
further importance, these effects of capsaicin were only observed
when TRPV1 stimulation was employed daily from day 0 ofated for 24 h by a ‘‘pro-inﬂammatory cytokine cocktail” (to induce mDCs), 1 lM
f CD83 and CCR7 maturation markers on DCs. (B and C) Q-PCR analysis of CD83 and
me sample and are expressed as mean ± S.E.M. of three independent determinations.
d cytokines measured by ELISA. Data represent mean ± S.E.M. of three independent
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ineffective in modifying the differentiation of iDCs (Fig. 2D). This
latter ﬁnding suggests that the speciﬁc TRPV1-signaling interferes
with the early events of DC differentiation; hence, when mono-
cytes are already committed to the DC lineage, the activation of
the existing TRPV1 cannot impede the process.
Another characteristic of iDCs is the capability of phagocytosis
[11,12,16]; hence, we also investigated the involvement of
TRPV1-signaling in this process. As assessed by E. coli-FITC inter-
nalization FLIPR analysis, in those cells which were treated by IL-
4 and GM-CSF in the presence of capsaicin from day 0 for 5 days
(i.e. during the ‘‘regular” iDC differentiation process), the phagocy-
totic activity was signiﬁcantly suppressed (Fig. 3A). In addition, we
also found that the co-application of capsazepine prevented the ac-
tion of prolonged capsaicin administration to suppress phagocyto-
sis (Fig. 3A) again arguing for the TRPV1-speciﬁcity of the effect of
capsaicin.
We then measured the effect of ‘‘acute” application of capsaicin
on the phagocytosis of the iDCs. As seen in Fig. 3B and C, as short as
2 h capsaicin treatment signiﬁcantly inhibited the phagocytotic
activity. Moreover, we also found that both capsazepine as well
as the suppression of extracellular Ca2+-concentration abrogated
this effect, again suggesting that (i) the capsaicin-induced inhibi-
tion of phagocytosis was mediated by TRPV1; and (ii) TRPV1 in-
deed functions as a Ca2+-permeable channel on iDCs.
3.2. TRPV1-signaling inhibits DC activation and maturation
As seen in Fig. 1, the expression of TRPV1 found on iDCs re-
mained substantially high when the maturation of iDCs to mDCs
was induced by a ‘‘pro-inﬂammatory cytokine cocktail” applied
for 24 h. Therefore, we also assessed the role of TRPV1 in the mat-
uration and activation of iDCs. In contrast to results obtained with
mouse DCs [13], capsaicin alone (i.e. without a ‘‘pro-inﬂammatory
cytokine cocktail”) failed to induce the maturation of iDCs to mDCs
as measured by assessing the expression of the mDCmarkers CD83
and CCR7 [11,12,16] (Fig. 4A). Likewise, capsaicin did not promote
the release of selected pro-inﬂammatory cytokines (data not
shown), an indicator of activation of DCs [11,12,16].
Intriguingly, the ‘‘pro-inﬂammatory cytokine cocktail” induced
overexpression of CD83 and CCR7 (as well as their highly elevated
mRNA transcript level) was signiﬁcantly suppressed by capsaicin
in a TRPV1-speciﬁc manner (Fig. 4A and B). Likewise, capsaicin also
decreased the expression of HLA-DR as well as other co-stimula-
tory molecules (CD40, CD80, and CD86) induced by the pro-inﬂam-
matory cocktail (Supplementary Fig. S2). Moreover, capsaicin, via
TRPV1, signiﬁcantly yet differentially inhibited the action of the
‘‘cocktail” to stimulate the production and release of selected cyto-
kines (Fig. 4C and D). Namely, capsaicin did not affect the highly
elevated synthesis of the pro-inﬂammatory IL-8 whilst it effec-
tively inhibited the production and release of IL-6 and IL-12 of
mDCs. Intriguingly, capsaicin further stimulated the synthesis
and release of the rather anti-inﬂammatory IL-10. It appears, there-
fore, that TRPV1-mediated signaling, similar to ﬁndings on other
cell types [5,17], differentially affects the cytokine proﬁle of the
cells.
3.3. Concluding remarks
Collectively, the above data introduce TRPV1 as a novel player
in human monocyte-derived DC biology. Moreover, our ﬁndings
obtained on in vitro cultured cells suggest that the functional
TRPV1 expressed on DCs exhibits anti-inﬂammatory properties
since it inhibited the differentiation, maturation, phagocytosis,
and (selected) pro-inﬂammatory cytokine production of the DCs.
Further studies are therefore warranted to deﬁne the putativecross-talk between the sensory neuron- and the DC-localized
TRPV1-coupled signaling mechanisms in the regulation of the im-
mune-inﬂammatory responses of a given tissue. Likewise, it should
also be explored (most preferably in clinical trials) how and to
what extent the DC-localized TRPV1-mediated cellular actions
are involved in (or can be engaged to) the in vivo anti-inﬂamma-
tory effects of TRPV1-acting agents.Acknowledgments
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